Safety, Tolerability and Pharmacokinetics of Multiple Doses of AV-101 in Healthy Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01483846
Recruitment Status : Completed
First Posted : December 1, 2011
Last Update Posted : December 20, 2012
Cato Research
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
VistaGen Therapeutics, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2012
  Actual Study Completion Date : September 2012